AI guided early detection of Alzheimer's and Parkinson's

Early diagnosis of neurodegenerative diseases
is urgently needed

The current tests are costly, time consuming and focused on late stages of the disease.
At CogniScent we couple scientific research with machine learning expertise to design non invasive and real time tests that focuse on early symptoms and olfactory performance, speeding up diagnosis and cutting medical costs.

How it works

Insert your data on our app

Our test presents questions on your olfactory abilities and early symptoms. Thanks to the easy-to-use and inclusive interface of our app, patients can upload data by themselves or with the help of a nurse. We take care of data format and ensure data privacy

Our algorithm performs predictions

Using accurate machine learning algorithms, we identify patterns that are central to the classification of patients at risk

Real Time Assessment

We compute risk assessments (low, medium, high) for Alzheimer's and Parkinson's and based on the results, physicians give recommendations on further steps

Are you a medical professional or are you concerned for you or your relative developing Alzheimer's or Parkinson's?
Join our waitlist and get early access to our test!

* indicates required

Our Founding Team

Dr. Micol de Ruvo

Co-Founder and CTO

Masters in Biomedical Engineering and PhD in Computational Biology, with extensive experience in using algorithms to solve challenges in life science

Kai Lammel

Co-Founder and CEO

Several years of experience in product development and marketing in big corporates and commercial co-founder of a med-tech company

Our Advisors

Prof. Dr. med. Carsten Eggers

Scientific Advisor

Vice chair of the Department of Neurology and Full Professor at the Philipps University Clinic Marburg. He leads the PANAMA Network Alliance for Parkinson's patients.

  • Read More
  • Dr. med. Felix Schmidt

    Scientific Advisor

    Physician at the Department of Neurology at Charité University Hospital and researcher with a focus on olfactory disorders in neurologic diseases. He has 10 years of national and international experience in clinical studies.

  • Read More

  • Tracy Dorée

    Commercial Advisor

    Cofounder at Kindred, Llustre. Venture partner and Advisor. She sold consumer products to customers in Europe and the US.

    Franz Schubert

    Commercial Advisor

    CEO at QRSKIN with 15 years experience at Boehringer Mannheim in marketing development. He consulted pharma and diagnostics companies on market launch and reimbursement in different health care systems.


    Let's get in touch!

    Ready to collaborate with us or curious to know more about CogniScent?
    Drop us a message, we will contact you the earliest